Search

Background: HLA-DR4, a common antigen of HLA-DRB1, has multiple subtypes that are strongly associated with risk of type 1 diabetes (T1D); however, some are risk neutral or resistant. The pathobiological mechanism of HLA-DR4 subtypes remains to be elucidated. Methods: We used a population-based case-control study of T1D (962 patients and 636 controls) to decipher genetic associations of HLA-DR4 subtypes and specific residues with susceptibility to T1D. Using a birth cohort of 7865 children with periodically measured islet autoantibodies (GADA, IAA or IA-2A), we proposed to validate discovered genetic associations with a totally different study design and time-to-seroconversions prior to clinical onset of T1D. A novel analytic strategy hierarchically organized the HLA-DRB1 alleles by sequence similarity and identified critical amino acid residues by minimizing local genomic architecture and higher-order interactions. Findings: Three amino acid residues of HLA-DRB1 (beta 71, beta 74, beta 86) were found to be predictive of T1D risk in the population-based study. The " KAG" motif, corresponding to HLA-DRB1x04:01, was most strongly associated with T1D risk ([O]dds [R]atio=3.64, p = 3.19 x 10(-64)). Three less frequent motifs ("EAV", OR = 2.55, p = 0.025; "RAG", OR = 1.93, p = 0.043; and "RAV", OR = 1.56, p = 0.003) were associated with T1D risk, while two motifs ("REG" and "REV") were equally protective (OR = 0.11, p = 4.23 x 10(-4)). In an independent birth cohort of HLA-DR3 and HLA-DR4 subjects, those having the "KAG" motif had increased risk for time-to-seroconversion (Hazard Ratio = 1.74, p = 6.51 x 10(-14)) after adjusting potential confounders. Interpretations: DNA sequence variation in HLA-DRB1 at positions beta 71, beta 74, and beta 86 are non-conservative (beta 74 A -> E, beta 71 E vs K vs R and beta 86 G vs V). They result in substantial differences in peptide antigen anchor pocket preferences at p1, p4 and potentially neighboring regions such as pocket

Background: HLA-DR4, a common antigen of HLA-DRB1, has multiple subtypes that are strongly associated with risk of type 1 diabetes (T1D); however, some are risk neutral or resistant. The pathobiological mechanism of HLA-DR4 subtypes remains to be elucidated. Methods: We used a population-based case-control study of T1D (962 patients and 636 controls) to decipher genetic associations of HLA-DR4 subtypes and specific residues with susceptibility to T1D. Using a birth cohort of 7865 children with periodically measured islet autoantibodies (GADA, IAA or IA-2A), we proposed to validate discovered genetic associations with a totally different study design and time-to-seroconversions prior to clinical onset of T1D. A novel analytic strategy hierarchically organized the HLA-DRB1 alleles by sequence similarity and identified critical amino acid residues by minimizing local genomic architecture and higher-order interactions. Findings: Three amino acid residues of HLA-DRB1 (beta 71, beta 74, beta 86) were found to be predictive of T1D risk in the population-based study. The " KAG" motif, corresponding to HLA-DRB1x04:01, was most strongly associated with T1D risk ([O]dds [R]atio=3.64, p = 3.19 x 10(-64)). Three less frequent motifs ("EAV", OR = 2.55, p = 0.025; "RAG", OR = 1.93, p = 0.043; and "RAV", OR = 1.56, p = 0.003) were associated with T1D risk, while two motifs ("REG" and "REV") were equally protective (OR = 0.11, p = 4.23 x 10(-4)). In an independent birth cohort of HLA-DR3 and HLA-DR4 subjects, those having the "KAG" motif had increased risk for time-to-seroconversion (Hazard Ratio = 1.74, p = 6.51 x 10(-14)) after adjusting potential confounders. Interpretations: DNA sequence variation in HLA-DRB1 at positions beta 71, beta 74, and beta 86 are non-conservative (beta 74 A -> E, beta 71 E vs K vs R and beta 86 G vs V). They result in substantial differences in peptide antigen anchor pocket preferences at p1, p4 and potentially neighboring regions such as pocket

HLA-DQ molecules account over 50% genetic risk of type 1 diabetes (T1D), but little is known about associated residues. Through next generation targeted sequencing technology and deep learning of DQ residue sequences, the aim was to uncover critical residues and their motifs associated with T1D. Our analysis uncovered (alpha a1, alpha 44, alpha 157, alpha 196) and (beta 9, beta 30, beta 57, beta 70, beta 135) on the HLA-DQ molecule. Their motifs captured all known susceptibility and resistant T1D associations. Three motifs, "DCAA-YSARD" (OR=2.10, p=1.96*10(-20)), "DQAA-YYARD" (OR=3.34, 2.69*10(-72)) and "DQDA-YYARD" (OR=3.71, 1.53*10(-6)) corresponding to DQ2.5 and DQ8.1 (the latter two motifs) associated with susceptibility. Ten motifs were significantly associated with resistance to T1D. Collectively, homozygous DQ risk motifs accounted for 43% of DQ-T1D risk, while homozygous DQ resistant motifs accounted for 25% protection to DQ-T1D risk. Of the identified nine residues five were within or near anchoring pockets of the antigenic peptide (alpha 44, beta 9, beta 30, beta 57 and beta 70), one was the N-terminal of the alpha chain (alpha a1), one in the CD4-binding region (beta 135), one in the putative cognate TCR-induced alpha beta homodimerization process (alpha 157), and one in the intra-membrane domain of the alpha chain (alpha 196). Finding these critical residues should allow investigations of fundamental properties of host immunity that underlie tolerance to self and organ-specific autoimmunity., Funding Agencies|Lund University; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [1R01DK117276]; European Foundation for the Study of Diabetes (EFSD) Clinical Research Grants Programme 2013; Swedish Child Diabetes Foundation (Barndiabetesfonden); Swedish Foundation for Strategic ResearchSwedish Foundation for Strategic Research [IRC15-0067]; Swedish Research Council, Strategic Research AreaSwedish Research Council [2009-1039]; Skane County Council for Research and Development; Swedish Association of Local Authorities and Regions (SKL)

Background: HLA-DR4, a common antigen of HLA-DRB1, has multiple subtypes that are strongly associated with risk of type 1 diabetes (T1D); however, some are risk neutral or resistant. The pathobiological mechanism of HLA-DR4 subtypes remains to be elucidated. Methods: We used a population-based case-control study of T1D (962 patients and 636 controls) to decipher genetic associations of HLA-DR4 subtypes and specific residues with susceptibility to T1D. Using a birth cohort of 7865 children with periodically measured islet autoantibodies (GADA, IAA or IA-2A), we proposed to validate discovered genetic associations with a totally different study design and time-to-seroconversions prior to clinical onset of T1D. A novel analytic strategy hierarchically organized the HLA-DRB1 alleles by sequence similarity and identified critical amino acid residues by minimizing local genomic architecture and higher-order interactions. Findings: Three amino acid residues of HLA-DRB1 (beta 71, beta 74, beta 86) were found to be predictive of T1D risk in the population-based study. The " KAG" motif, corresponding to HLA-DRB1x04:01, was most strongly associated with T1D risk ([O]dds [R]atio=3.64, p = 3.19 x 10(-64)). Three less frequent motifs ("EAV", OR = 2.55, p = 0.025; "RAG", OR = 1.93, p = 0.043; and "RAV", OR = 1.56, p = 0.003) were associated with T1D risk, while two motifs ("REG" and "REV") were equally protective (OR = 0.11, p = 4.23 x 10(-4)). In an independent birth cohort of HLA-DR3 and HLA-DR4 subjects, those having the "KAG" motif had increased risk for time-to-seroconversion (Hazard Ratio = 1.74, p = 6.51 x 10(-14)) after adjusting potential confounders. Interpretations: DNA sequence variation in HLA-DRB1 at positions beta 71, beta 74, and beta 86 are non-conservative (beta 74 A -> E, beta 71 E vs K vs R and beta 86 G vs V). They result in substantial differences in peptide antigen anchor pocket preferences at p1, p4 and potentially neighboring regions such as pocket

HLA-DQ molecules account over 50% genetic risk of type 1 diabetes (T1D), but little is known about associated residues. Through next generation targeted sequencing technology and deep learning of DQ residue sequences, the aim was to uncover critical residues and their motifs associated with T1D. Our analysis uncovered (alpha a1, alpha 44, alpha 157, alpha 196) and (beta 9, beta 30, beta 57, beta 70, beta 135) on the HLA-DQ molecule. Their motifs captured all known susceptibility and resistant T1D associations. Three motifs, "DCAA-YSARD" (OR=2.10, p=1.96*10(-20)), "DQAA-YYARD" (OR=3.34, 2.69*10(-72)) and "DQDA-YYARD" (OR=3.71, 1.53*10(-6)) corresponding to DQ2.5 and DQ8.1 (the latter two motifs) associated with susceptibility. Ten motifs were significantly associated with resistance to T1D. Collectively, homozygous DQ risk motifs accounted for 43% of DQ-T1D risk, while homozygous DQ resistant motifs accounted for 25% protection to DQ-T1D risk. Of the identified nine residues five were within or near anchoring pockets of the antigenic peptide (alpha 44, beta 9, beta 30, beta 57 and beta 70), one was the N-terminal of the alpha chain (alpha a1), one in the CD4-binding region (beta 135), one in the putative cognate TCR-induced alpha beta homodimerization process (alpha 157), and one in the intra-membrane domain of the alpha chain (alpha 196). Finding these critical residues should allow investigations of fundamental properties of host immunity that underlie tolerance to self and organ-specific autoimmunity., Funding Agencies|Lund University; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [1R01DK117276]; European Foundation for the Study of Diabetes (EFSD) Clinical Research Grants Programme 2013; Swedish Child Diabetes Foundation (Barndiabetesfonden); Swedish Foundation for Strategic ResearchSwedish Foundation for Strategic Research [IRC15-0067]; Swedish Research Council, Strategic Research AreaSwedish Research Council [2009-1039]; Skane County Council for Research and Development; Swedish Association of Local Authorities and Regions (SKL)

Background: HLA-DR4, a common antigen of HLA-DRB1, has multiple subtypes that are strongly associated with risk of type 1 diabetes (T1D); however, some are risk neutral or resistant. The pathobiological mechanism of HLA-DR4 subtypes remains to be elucidated. Methods: We used a population-based case-control study of T1D (962 patients and 636 controls) to decipher genetic associations of HLA-DR4 subtypes and specific residues with susceptibility to T1D. Using a birth cohort of 7865 children with periodically measured islet autoantibodies (GADA, IAA or IA-2A), we proposed to validate discovered genetic associations with a totally different study design and time-to-seroconversions prior to clinical onset of T1D. A novel analytic strategy hierarchically organized the HLA-DRB1 alleles by sequence similarity and identified critical amino acid residues by minimizing local genomic architecture and higher-order interactions. Findings: Three amino acid residues of HLA-DRB1 (beta 71, beta 74, beta 86) were found to be predictive of T1D risk in the population-based study. The " KAG" motif, corresponding to HLA-DRB1x04:01, was most strongly associated with T1D risk ([O]dds [R]atio=3.64, p = 3.19 x 10(-64)). Three less frequent motifs ("EAV", OR = 2.55, p = 0.025; "RAG", OR = 1.93, p = 0.043; and "RAV", OR = 1.56, p = 0.003) were associated with T1D risk, while two motifs ("REG" and "REV") were equally protective (OR = 0.11, p = 4.23 x 10(-4)). In an independent birth cohort of HLA-DR3 and HLA-DR4 subjects, those having the "KAG" motif had increased risk for time-to-seroconversion (Hazard Ratio = 1.74, p = 6.51 x 10(-14)) after adjusting potential confounders. Interpretations: DNA sequence variation in HLA-DRB1 at positions beta 71, beta 74, and beta 86 are non-conservative (beta 74 A -> E, beta 71 E vs K vs R and beta 86 G vs V). They result in substantial differences in peptide antigen anchor pocket preferences at p1, p4 and potentially neighboring regions such as pocket

HLA-DQ molecules account over 50% genetic risk of type 1 diabetes (T1D), but little is known about associated residues. Through next generation targeted sequencing technology and deep learning of DQ residue sequences, the aim was to uncover critical residues and their motifs associated with T1D. Our analysis uncovered (alpha a1, alpha 44, alpha 157, alpha 196) and (beta 9, beta 30, beta 57, beta 70, beta 135) on the HLA-DQ molecule. Their motifs captured all known susceptibility and resistant T1D associations. Three motifs, "DCAA-YSARD" (OR=2.10, p=1.96*10(-20)), "DQAA-YYARD" (OR=3.34, 2.69*10(-72)) and "DQDA-YYARD" (OR=3.71, 1.53*10(-6)) corresponding to DQ2.5 and DQ8.1 (the latter two motifs) associated with susceptibility. Ten motifs were significantly associated with resistance to T1D. Collectively, homozygous DQ risk motifs accounted for 43% of DQ-T1D risk, while homozygous DQ resistant motifs accounted for 25% protection to DQ-T1D risk. Of the identified nine residues five were within or near anchoring pockets of the antigenic peptide (alpha 44, beta 9, beta 30, beta 57 and beta 70), one was the N-terminal of the alpha chain (alpha a1), one in the CD4-binding region (beta 135), one in the putative cognate TCR-induced alpha beta homodimerization process (alpha 157), and one in the intra-membrane domain of the alpha chain (alpha 196). Finding these critical residues should allow investigations of fundamental properties of host immunity that underlie tolerance to self and organ-specific autoimmunity., Funding Agencies|Lund University; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [1R01DK117276]; European Foundation for the Study of Diabetes (EFSD) Clinical Research Grants Programme 2013; Swedish Child Diabetes Foundation (Barndiabetesfonden); Swedish Foundation for Strategic ResearchSwedish Foundation for Strategic Research [IRC15-0067]; Swedish Research Council, Strategic Research AreaSwedish Research Council [2009-1039]; Skane County Council for Research and Development; Swedish Association of Local Authorities and Regions (SKL)

Background: HLA-DR4, a common antigen of HLA-DRB1, has multiple subtypes that are strongly associated with risk of type 1 diabetes (T1D); however, some are risk neutral or resistant. The pathobiological mechanism of HLA-DR4 subtypes remains to be elucidated. Methods: We used a population-based case-control study of T1D (962 patients and 636 controls) to decipher genetic associations of HLA-DR4 subtypes and specific residues with susceptibility to T1D. Using a birth cohort of 7865 children with periodically measured islet autoantibodies (GADA, IAA or IA-2A), we proposed to validate discovered genetic associations with a totally different study design and time-to-seroconversions prior to clinical onset of T1D. A novel analytic strategy hierarchically organized the HLA-DRB1 alleles by sequence similarity and identified critical amino acid residues by minimizing local genomic architecture and higher-order interactions. Findings: Three amino acid residues of HLA-DRB1 (beta 71, beta 74, beta 86) were found to be predictive of T1D risk in the population-based study. The " KAG" motif, corresponding to HLA-DRB1x04:01, was most strongly associated with T1D risk ([O]dds [R]atio=3.64, p = 3.19 x 10(-64)). Three less frequent motifs ("EAV", OR = 2.55, p = 0.025; "RAG", OR = 1.93, p = 0.043; and "RAV", OR = 1.56, p = 0.003) were associated with T1D risk, while two motifs ("REG" and "REV") were equally protective (OR = 0.11, p = 4.23 x 10(-4)). In an independent birth cohort of HLA-DR3 and HLA-DR4 subjects, those having the "KAG" motif had increased risk for time-to-seroconversion (Hazard Ratio = 1.74, p = 6.51 x 10(-14)) after adjusting potential confounders. Interpretations: DNA sequence variation in HLA-DRB1 at positions beta 71, beta 74, and beta 86 are non-conservative (beta 74 A -> E, beta 71 E vs K vs R and beta 86 G vs V). They result in substantial differences in peptide antigen anchor pocket preferences at p1, p4 and potentially neighboring regions such as pocket

Background: HLA-DR4, a common antigen of HLA-DRB1, has multiple subtypes that are strongly associated with risk of type 1 diabetes (T1D); however, some are risk neutral or resistant. The pathobiological mechanism of HLA-DR4 subtypes remains to be elucidated. Methods: We used a population-based case-control study of T1D (962 patients and 636 controls) to decipher genetic associations of HLA-DR4 subtypes and specific residues with susceptibility to T1D. Using a birth cohort of 7865 children with periodically measured islet autoantibodies (GADA, IAA or IA-2A), we proposed to validate discovered genetic associations with a totally different study design and time-to-seroconversions prior to clinical onset of T1D. A novel analytic strategy hierarchically organized the HLA-DRB1 alleles by sequence similarity and identified critical amino acid residues by minimizing local genomic architecture and higher-order interactions. Findings: Three amino acid residues of HLA-DRB1 (beta 71, beta 74, beta 86) were found to be predictive of T1D risk in the population-based study. The " KAG" motif, corresponding to HLA-DRB1x04:01, was most strongly associated with T1D risk ([O]dds [R]atio=3.64, p = 3.19 x 10(-64)). Three less frequent motifs ("EAV", OR = 2.55, p = 0.025; "RAG", OR = 1.93, p = 0.043; and "RAV", OR = 1.56, p = 0.003) were associated with T1D risk, while two motifs ("REG" and "REV") were equally protective (OR = 0.11, p = 4.23 x 10(-4)). In an independent birth cohort of HLA-DR3 and HLA-DR4 subjects, those having the "KAG" motif had increased risk for time-to-seroconversion (Hazard Ratio = 1.74, p = 6.51 x 10(-14)) after adjusting potential confounders. Interpretations: DNA sequence variation in HLA-DRB1 at positions beta 71, beta 74, and beta 86 are non-conservative (beta 74 A -> E, beta 71 E vs K vs R and beta 86 G vs V). They result in substantial differences in peptide antigen anchor pocket preferences at p1, p4 and potentially neighboring regions such as pocket

HLA-DQ molecules account over 50% genetic risk of type 1 diabetes (T1D), but little is known about associated residues. Through next generation targeted sequencing technology and deep learning of DQ residue sequences, the aim was to uncover critical residues and their motifs associated with T1D. Our analysis uncovered (alpha a1, alpha 44, alpha 157, alpha 196) and (beta 9, beta 30, beta 57, beta 70, beta 135) on the HLA-DQ molecule. Their motifs captured all known susceptibility and resistant T1D associations. Three motifs, "DCAA-YSARD" (OR=2.10, p=1.96*10(-20)), "DQAA-YYARD" (OR=3.34, 2.69*10(-72)) and "DQDA-YYARD" (OR=3.71, 1.53*10(-6)) corresponding to DQ2.5 and DQ8.1 (the latter two motifs) associated with susceptibility. Ten motifs were significantly associated with resistance to T1D. Collectively, homozygous DQ risk motifs accounted for 43% of DQ-T1D risk, while homozygous DQ resistant motifs accounted for 25% protection to DQ-T1D risk. Of the identified nine residues five were within or near anchoring pockets of the antigenic peptide (alpha 44, beta 9, beta 30, beta 57 and beta 70), one was the N-terminal of the alpha chain (alpha a1), one in the CD4-binding region (beta 135), one in the putative cognate TCR-induced alpha beta homodimerization process (alpha 157), and one in the intra-membrane domain of the alpha chain (alpha 196). Finding these critical residues should allow investigations of fundamental properties of host immunity that underlie tolerance to self and organ-specific autoimmunity., Funding Agencies|Lund University; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [1R01DK117276]; European Foundation for the Study of Diabetes (EFSD) Clinical Research Grants Programme 2013; Swedish Child Diabetes Foundation (Barndiabetesfonden); Swedish Foundation for Strategic ResearchSwedish Foundation for Strategic Research [IRC15-0067]; Swedish Research Council, Strategic Research AreaSwedish Research Council [2009-1039]; Skane County Council for Research and Development; Swedish Association of Local Authorities and Regions (SKL)

HLA-DQ molecules account over 50% genetic risk of type 1 diabetes (T1D), but little is known about associated residues. Through next generation targeted sequencing technology and deep learning of DQ residue sequences, the aim was to uncover critical residues and their motifs associated with T1D. Our analysis uncovered (alpha a1, alpha 44, alpha 157, alpha 196) and (beta 9, beta 30, beta 57, beta 70, beta 135) on the HLA-DQ molecule. Their motifs captured all known susceptibility and resistant T1D associations. Three motifs, "DCAA-YSARD" (OR=2.10, p=1.96*10(-20)), "DQAA-YYARD" (OR=3.34, 2.69*10(-72)) and "DQDA-YYARD" (OR=3.71, 1.53*10(-6)) corresponding to DQ2.5 and DQ8.1 (the latter two motifs) associated with susceptibility. Ten motifs were significantly associated with resistance to T1D. Collectively, homozygous DQ risk motifs accounted for 43% of DQ-T1D risk, while homozygous DQ resistant motifs accounted for 25% protection to DQ-T1D risk. Of the identified nine residues five were within or near anchoring pockets of the antigenic peptide (alpha 44, beta 9, beta 30, beta 57 and beta 70), one was the N-terminal of the alpha chain (alpha a1), one in the CD4-binding region (beta 135), one in the putative cognate TCR-induced alpha beta homodimerization process (alpha 157), and one in the intra-membrane domain of the alpha chain (alpha 196). Finding these critical residues should allow investigations of fundamental properties of host immunity that underlie tolerance to self and organ-specific autoimmunity., Funding Agencies|Lund University; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [1R01DK117276]; European Foundation for the Study of Diabetes (EFSD) Clinical Research Grants Programme 2013; Swedish Child Diabetes Foundation (Barndiabetesfonden); Swedish Foundation for Strategic ResearchSwedish Foundation for Strategic Research [IRC15-0067]; Swedish Research Council, Strategic Research AreaSwedish Research Council [2009-1039]; Skane County Council for Research and Development; Swedish Association of Local Authorities and Regions (SKL)

HLA-DQA1 and -DQB1 genes have significant and potentially causal associations with autoimmune type 1 diabetes (T1D). To follow up on the earlier analysis on high-risk HLA-DQ2.5 and DQ8.1, the current analysis uncovers seven residues (alpha a1, alpha 157, alpha 196, beta 9, beta 30, beta 57, and beta 70) that are resistant to T1D among subjects with DQ4-, 5-, 6-, and7-resistant DQ haplotypes. These 7 residues form 13 common motifs: 6 motifs are significantly resistant, 6 motifs have modest or no associations (Pvalues >0.05), and 1 motif has 7 copies observed among control subjects only. The motifs "DAAFYDG," "DAAYHDG," and "DAAYYDR" have significant resistance to T1D (odds ratios [ORs] 0.03, 0.25, and 0.18;P= 6.11 x 10(-24), 3.54 x 10(-15), and 1.03 x 10(-21), respectively). Remarkably, a change of a single residue from the motif "DAAYHDG" to "DAAYHSG" (D to S at beta 57) alters the resistance potential, from resistant motif (OR 0.15;P= 3.54 x 10(-15)) to a neutral motif (P= 0.183), the change of which was significant (FisherPvalue = 0.0065). The extended set of linked residues associated with T1D resistance and unique to each cluster of HLA-DQ haplotypes represents facets of all known features and functions of these molecules: antigenic peptide binding, peptide-MHC class II complex stability, beta 167-169 RGD loop, T-cell receptor binding, formation of homodimer of alpha-beta heterodimers, and cholesterol binding in the cell membrane rafts. Identification of these residues is a novel understanding of resistant DQ associations with T1D. Our analyses endow potential molecular approaches to identify immunological mechanisms that control disease susceptibility or resistance to provide novel targets for immunotherapeutic strategies., Funding Agencies|National Institutes of Health/National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [1R56 DK117276, DK63861, DK26190]; European Foundation for the Study of Diabetes Clinical Research Grants Programme 2013; Swedish Child Diabetes Foundation (Barndiabetesfonden); Swedish Research CouncilSwedish Research Council; Linne grant; Skane County Council for Research and Development; Swedish Association of Local Authorities and Regions

HLA-DQA1 and -DQB1 are strongly associated with type 1 diabetes (T1D), and DQ8.1 and DQ2.5 are major risk haplotypes. Next-generation targeted sequencing of HLA-DQA1 and -DQB1 in Swedish newly diagnosed 1- to 18 year-old patients (n= 962) and control subjects (n= 636) was used to construct abbreviated DQ haplotypes, converted into amino acid (AA) residues, and assessed for their associations with T1D. A hierarchically organized haplotype (HOH) association analysis allowed 45 unique DQ haplotypes to be categorized into seven clusters. The DQ8/9 cluster included two DQ8.1 risk and the DQ9 resistant haplotypes, and the DQ2 cluster included the DQ2.5 risk and DQ2.2 resistant haplotypes. Within each cluster, HOH found residues alpha 44Q (odds ratio [OR] 3.29,P= 2.38 * 10(-85)) and beta 57A (OR 3.44,P= 3.80 * 10(-84)) to be associated with T1D in the DQ8/9 cluster representing all ten residues (alpha 22, alpha 23, alpha 44, alpha 49, alpha 51, alpha 53, alpha 54, alpha 73, alpha 184, beta 57) due to complete linkage disequilibrium (LD) of alpha 44 with eight such residues. Within the DQ2 cluster and due to LD, HOH analysis found alpha 44C and beta 135D to share the risk for T1D (OR 2.10,P= 1.96 * 10(-20)). The motif "QAD" of alpha 44, beta 57, and beta 135 captured the T1D risk association of DQ8.1 (OR 3.44,P= 3.80 * 10(-84)), and the corresponding motif "CAD" captured the risk association of DQ2.5 (OR 2.10,P= 1.96 * 10(-20)). Two risk associations were related to GAD65 autoantibody (GADA) and IA-2 autoantibody (IA-2A) but in opposite directions. CAD was positively associated with GADA (OR 1.56,P= 6.35 * 10(-8)) but negatively with IA-2A (OR 0.59,P= 6.55 * 10(-11)). QAD was negatively associated with GADA (OR 0.88;P= 3.70 * 10(-3)) but positively with IA-2A (OR 1.64;P= 2.40 * 10(-14)), despite a single difference at alpha 44. The residues are found in and around anchor pockets 1 and 9, as potential T-cell receptor contacts, in the areas for CD4 binding and putative homodi, Funding Agencies|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [1R01DK117276]; European Foundation for the Study of Diabetes; Swedish Child Diabetes Foundation (Barndiabetesfonden); NIDDK, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK63861, DK26190]; Swedish Research CouncilSwedish Research Council; Skane County Council for Research and Development; Swedish Association of Local Authorities and Regions (SKL)

Next-generation targeted sequencing of HLA-DRB1 and HLA-DRB3, -DRB4, and -DRB5 (abbreviated as DRB345) provides high resolution of functional variant positions to investigate their associations with type 1 diabetes risk and with autoantibodies against insulin (IAA), GAD65 (GADA), IA-2 (IA-2A), and ZnT8 (ZnT8A). To overcome exceptional DR sequence complexity as a result of high polymorphisms and extended linkage disequilibrium among the DR loci, we applied a novel recursive organizer (ROR) to discover disease-associated amino acid residues. ROR distills disease-associated DR sequences and identifies 11 residues of DRB1, sequences of which retain all significant associations observed by DR genes. Furthermore, all 11 residues locate under/adjoining the peptide-binding groove of DRB1, suggesting a plausible functional mechanism through peptide binding. The 15 residues of DRB345, located respectively in the beta 49-55 homodimerization patch and on the face of the molecule shown to interact with and bind to the accessory molecule CD4, retain their significant disease associations. Further ROR analysis of DR associations with autoantibodies finds that DRB1 residues significantly associated with ZnT8A and DRB345 residues with GADA. The strongest association is between four residues (beta 14, beta 25, beta 71, and beta 73) and IA-2A, in which the sequence ERKA confers a risk association (odds ratio 2.15, P = 10(-18)), and another sequence, ERKG, confers a protective association (odds ratio 0.59, P = 10(-11)), despite a difference of only one amino acid. Because motifs of identified residues capture potentially causal DR associations with type 1 diabetes, this list of residuals is expected to include corresponding causal residues in this study population., Funding Agencies|National Institute of Diabetes and Digestive and Kidney Diseases [R56-DK-117276, R01-DK-117276, DK-63861, DK-26190]; European Foundation for the Study of Diabetes Clinical Research Grants Programme 2013; Swedish Child Diabetes Foundation (Barndiabetesfonden); Swedish Research Council; Skane County Council for Research and Development; Swedish Association of Local Authorities and Regions; Forskningsradet om Halsa, Arbetsliv och Valfard; European Union [MIS 91949]